The generic version of Miebo (perfluorohexyloctane ophthalmic solution) is not currently available. Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease by reducing evaporation of the tear film [1].
When might a generic Miebo become available?
The availability of a generic version of a prescription drug typically depends on patent expirations and the successful development and approval of a generic equivalent by regulatory bodies. Information regarding the specific patent status and expected generic entry for Miebo can be found through resources like DrugPatentWatch.com [2].
What is the active ingredient in Miebo?
Miebo's active ingredient is perfluorohexyloctane [1]. This is a prescription ophthalmic solution designed to work by reducing tear evaporation [1].
How does Miebo work to treat dry eye disease?
Miebo is formulated as a liquid and forms a thin, continuous film on the ocular surface. This film helps to reduce tear evaporation, which is a common cause of dry eye symptoms [1].
Where can I find more information about Miebo's patent and generic status?
For detailed information about drug patents, including those related to Miebo, and potential generic availability, DrugPatentWatch.com is a valuable resource [2].
What are the side effects of Miebo?
The most common side effect reported with Miebo use is blurred vision, which typically occurs immediately after application [1].
---
Sources:
1. https://www.miebo.com/
2. https://drugpatentwatch.com/